Skip to main content
OpenTrials
Completed

NCT Number: NCT03297853

Prevalence, Management and Follow-up of Patients With Addiction to Opioid Analgesics

The demand for addiction care for patients with addiction to analgesics increases with the number of prescription of analgesics grade 2; this is a public health problem There is no support for repositories to date in the context of addiction analgesics grade 2.

Risk factors of misuse as well as diagnostic tools were identified.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Uhmontpellier

Montpellier, 34295, France

About this study

The demand for addiction care for patients with addiction to analgesics increases with the number of prescription of analgesics grade 2; this is a public health problem There is no support for repositories to date in the context of addiction analgesics grade 2.

Risk factors of misuse as well as diagnostic tools were identified. The objectives of our research are to determine the characteristics of the individuals suffering from an addiction to analgesics of level 2 followed in consultation of addictology in the hospital of Montpellier and Nimes and to describe the type of follow-up proposed to the patients in these two centers. It is a retrospective and descriptive study.

As part of this research, we will solicit all the patients followed in consultation of addictology or in hospitalization to the hospital of Montpellier or Nîmes for an addiction to the analgesics of grade 2 between the 1st of January 2014 and the 10th of July 2017 with requests of management for withdrawal or reduction of doses, opioid analgesics in the absence of pain or in chronic non-cancer pain, opioid analgesics to avoid withdrawal syndrome or hyperalgesia and consumptions chronic to dosages inadequate to the functional complaint evaluated by the rhumatology or algology services.

The data are collected in the medical file at the two participating institutions (Montpellier and Nîmes) and if necessary, patients not seen in consultation for more than 6 months will be recontacted.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Requests for management for weaning or reduction of doses
  • Take opioid analgesics in the absence of pain or as part of chronic non-cancer pain
  • Opioid analgesics to prevent withdrawal syndrome or hyperalgesia
  • Chronic consumption at inadequate dosages compared to the functional complaint evaluated by the MPR / Algologie services
  • Patients over 18 years and who agree with the study

Exclusion criteria

  • language barrier
  • severe cognitive and / or psychiatric disorders

Treatment and study plan

Primary outcomes

  1. 50/5000 Prevalence of demand for care in addictology

    Time frame: 1 day

    Prevalence of demand for addictive care in subjects with addiction to analgesics in level 2

Secondary outcomes

  1. Types of support proposed

    Time frame: 1 day

    Types of support proposed

  2. Assessment of analgesic dependence

    Time frame: 1 day

    Assessment of analgesic dependence

  3. History of analgesic use

    Time frame: 1 day

    History of analgesic use

  4. quality of life

    Time frame: 1 day

    quality of life

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Important dates

Study start
2014
Primary completion
2017
Study completion
2018
First posted
Sep 29, 2017
Registry last updated
May 7, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.